421 related articles for article (PubMed ID: 24552512)
21. Possible drugs for the treatment of bacterial infections in the future: anti-virulence drugs.
Ogawara H
J Antibiot (Tokyo); 2021 Jan; 74(1):24-41. PubMed ID: 32647212
[TBL] [Abstract][Full Text] [Related]
22. Targeting virulence for antimicrobial chemotherapy.
Lee YM; Almqvist F; Hultgren SJ
Curr Opin Pharmacol; 2003 Oct; 3(5):513-9. PubMed ID: 14559097
[TBL] [Abstract][Full Text] [Related]
23. Bactericidal, quorum quenching and anti-biofilm nanofactories: a new niche for nanotechnologists.
Singh BN; Prateeksha ; Upreti DK; Singh BR; Defoirdt T; Gupta VK; De Souza AO; Singh HB; Barreira JC; Ferreira IC; Vahabi K
Crit Rev Biotechnol; 2017 Jun; 37(4):525-540. PubMed ID: 27684212
[TBL] [Abstract][Full Text] [Related]
24. Fighting the enemy within.
Tacconelli E; Autenrieth IB; Peschel A
Science; 2017 Feb; 355(6326):689-690. PubMed ID: 28209857
[No Abstract] [Full Text] [Related]
25. [Quorum sensing and quorum quenching: how to disrupt bacterial communication to inhibit virulence?].
Mion S; Rémy B; Plener L; Chabrière É; Daudé D
Med Sci (Paris); 2019 Jan; 35(1):31-38. PubMed ID: 30672458
[TBL] [Abstract][Full Text] [Related]
26. Novel Antibacterial Agents: An Emergent Need to Win the Battle Against Infections.
Simões NG; Bettencourt AF; Monge N; Ribeiro IAC
Mini Rev Med Chem; 2017; 17(14):1364-1376. PubMed ID: 27629996
[TBL] [Abstract][Full Text] [Related]
27. Fatty Acids as Antibiofilm and Antivirulence Agents.
Kumar P; Lee JH; Beyenal H; Lee J
Trends Microbiol; 2020 Sep; 28(9):753-768. PubMed ID: 32359781
[TBL] [Abstract][Full Text] [Related]
28. Antibiotic resistance and virulence: Understanding the link and its consequences for prophylaxis and therapy.
Guillard T; Pons S; Roux D; Pier GB; Skurnik D
Bioessays; 2016 Jul; 38(7):682-93. PubMed ID: 27248008
[TBL] [Abstract][Full Text] [Related]
29. Repurposing of Anticancer Drugs for the Treatment of Bacterial Infections.
Soo VW; Kwan BW; Quezada H; Castillo-Juárez I; Pérez-Eretza B; García-Contreras SJ; Martínez-Vázquez M; Wood TK; García-Contreras R
Curr Top Med Chem; 2017; 17(10):1157-1176. PubMed ID: 27697046
[TBL] [Abstract][Full Text] [Related]
30. [Research progress of new antibacterial drugs that target bacterial quorum sensing systems].
Yin SL; Chang YJ; Deng SP; Wang QC; Yu WG; Gong QH
Yao Xue Xue Bao; 2011 Jun; 46(6):613-21. PubMed ID: 21882519
[TBL] [Abstract][Full Text] [Related]
31. Combating multidrug-resistant bacteria: current strategies for the discovery of novel antibacterials.
O'Connell KM; Hodgkinson JT; Sore HF; Welch M; Salmond GP; Spring DR
Angew Chem Int Ed Engl; 2013 Oct; 52(41):10706-33. PubMed ID: 24038605
[TBL] [Abstract][Full Text] [Related]
32. Strategies to Overcome Antimicrobial Resistance (AMR) Making Use of Non-Essential Target Inhibitors: A Review.
Annunziato G
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31766441
[TBL] [Abstract][Full Text] [Related]
33. Virulence as a target for antimicrobial chemotherapy.
Alksne LE
Expert Opin Investig Drugs; 2002 Aug; 11(8):1149-59. PubMed ID: 12150708
[TBL] [Abstract][Full Text] [Related]
34. The fallacies of hope: will we discover new antibiotics to combat pathogenic bacteria in time?
Vicente M; Hodgson J; Massidda O; Tonjum T; Henriques-Normark B; Ron EZ
FEMS Microbiol Rev; 2006 Nov; 30(6):841-52. PubMed ID: 17064283
[TBL] [Abstract][Full Text] [Related]
35. Specific Antivirulence Activity, A New Concept for Reliable Screening of Virulence Inhibitors.
Defoirdt T
Trends Biotechnol; 2016 Jul; 34(7):527-529. PubMed ID: 26879186
[TBL] [Abstract][Full Text] [Related]
36. Pathogenic bacteria: how to get them back into the line of fire?
Keck W; Hubschwerlen C
Curr Opin Investig Drugs; 2005 Feb; 6(2):139-40. PubMed ID: 15751735
[No Abstract] [Full Text] [Related]
37. Approaches targeting the type III secretion system to treat or prevent bacterial infections.
Charro N; Mota LJ
Expert Opin Drug Discov; 2015 Apr; 10(4):373-87. PubMed ID: 25727140
[TBL] [Abstract][Full Text] [Related]
38. Quorum sensing and microbial drug resistance.
Chen YF; Liu SY; Liang ZB; Lv MF; Zhou JN; Zhang LH
Yi Chuan; 2016 Oct; 38(10):881-893. PubMed ID: 27806929
[TBL] [Abstract][Full Text] [Related]
39. Addressing the frustrations of finding new effective antibacterials to combat drug resistant bacteria.
Fernandes P; Pizza M
Curr Opin Microbiol; 2008 Oct; 11(5):385-6. PubMed ID: 18804177
[No Abstract] [Full Text] [Related]
40. Global priority pathogens: virulence, antimicrobial resistance and prospective treatment options.
M Campos JC; Antunes LC; Ferreira RB
Future Microbiol; 2020 May; 15():649-677. PubMed ID: 32495702
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
